{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:04:46Z","timestamp":1783919086760,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance. However, its prognostic significance in patients with colorectal cancer liver metastases (CRLM) remains unclear. This study aimed to investigate its prognostic value and develop a machine learning (ML) - based predictive model in CRLM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 644 patients with synchronous CRLM who underwent curative-intent treatment were enrolled in this single-center retrospective study. The association between the TyG index and overall survival (OS) was assessed using Kaplan-Meier analysis and Cox regression models. Key predictive variables were selected via LASSO regression and six ML algorithms, which were then utilized to construct a nomogram. The model\u2019s performance was evaluated by the C-index and the area under the receiver operating characteristic curve (AUC), and compared against classical clinical risk scores (CRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The research revealed an inverse association between TyG index and CRLM. Multiple analyses confirmed that a low TyG index was an independent risk factor for shortened OS. ML methods identified nine key variables, including the TyG index, for nomogram construction. The nomogram demonstrated improved predictive performance in individualized prognosis prediction compared to the CRS: C-index 0.697 (95% CI: 0.627\u20130.767) vs. 0.631 (95% CI: 0.559\u20130.703); 5-year AUC 0.829 (95% CI: 0.755\u20130.904) vs. 0.741 (95% CI: 0.646\u20130.836).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Unlike what was observed in previous studies, a low TyG index was associated with poor prognosis in CRLM. The ML-derived predictive model showed potential for OS prediction and clinical application, but further external validation is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1842975","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:23:12Z","timestamp":1783916592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cParadoxical\u201d prognostic role of the TyG index and a novel machine learning-derived nomogram for colorectal cancer liver metastases"],"prefix":"10.3389","volume":"13","author":[{"given":"Taijun","family":"Yi","sequence":"first","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunle","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]},{"name":"The Sixth Affiliated Hospital, Biomedical Innovation Center, Sun Yat-sen University, Guangzhou","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025.","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: A Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.3390\/ijms21155255","article-title":"Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? a comprehensive review.","volume":"21","author":"Filip","year":"2020","journal-title":"Intern J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/1570161114666161007164510","article-title":"Link between metabolic syndrome and insulin resistance.","volume":"15","author":"Gluvic","year":"2017","journal-title":"Curr Vascular Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41388-018-0222-3","article-title":"Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.","volume":"37","author":"Chu","year":"2018","journal-title":"Oncogene."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","article-title":"Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases.","volume":"131","author":"Sun","year":"2025","journal-title":"Eur J Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1186\/s12885-022-10100-w","article-title":"Association between the TyG index and TG\/HDL-C ratio as insulin resistance markers and the risk of colorectal cancer.","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12957-025-03930-y","article-title":"Association between the triglyceride-glucose index (TyG Index) and risk of colorectal cancer: a systematic review and meta-analysis.","volume":"23","author":"Omer","year":"2025","journal-title":"World J Surg Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1186\/s12885-025-14625-8","article-title":"Association of triglyceride-glucose related indices with colorectal cancer risk among the US population: a cross-sectional study.","volume":"25","author":"Niu","year":"2025","journal-title":"BMC Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1098492","DOI":"10.3389\/fendo.2022.1098492","article-title":"Association between triglyceride glucose index and risk of cancer: a meta-analysis.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"585388","DOI":"10.3389\/fonc.2021.585388","article-title":"Association between triglyceride glucose index and non-small cell Lung cancer risk in Chinese population.","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1321622","DOI":"10.3389\/fendo.2024.1321622","article-title":"Association between triglyceride glucose index and breast cancer in 142,184 Chinese adults: findings from the REACTION study.","volume":"15","author":"Wu","year":"2024","journal-title":"Front Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-024-00332-8","article-title":"Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia.","volume":"12","author":"Ruan","year":"2024","journal-title":"Cancer Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ije\/dyz053","article-title":"The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers.","volume":"49","author":"Fritz","year":"2020","journal-title":"Intern J Epidemiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41416-023-02526-1","article-title":"Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts.","volume":"130","author":"Fritz","year":"2024","journal-title":"Br J Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"774937","DOI":"10.3389\/fonc.2021.774937","article-title":"Triglyceride-Glucose index is not associated with lung cancer risk: a prospective cohort study in the UK biobank.","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12967-024-05524-w","article-title":"Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: implications for disease progression and prognosis.","volume":"22","author":"Song","year":"2024","journal-title":"J Trans Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1592788","DOI":"10.3389\/fendo.2025.1592788","article-title":"The triglyceride-glucose index associated with reduced risk of liver metastasis in pancreatic cancer.","volume":"16","author":"Yi","year":"2025","journal-title":"Front Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-023-02857-6","article-title":"Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption.","volume":"42","author":"Geaney","year":"2023","journal-title":"Oncogene."},{"key":"B19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/gut.50.5.642","article-title":"Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.","volume":"50","author":"Palmqvist","year":"2002","journal-title":"Gut."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00018-015-1840-3","article-title":"Dysregulated glycolysis as an oncogenic event.","volume":"72","author":"Mikawa","year":"2015","journal-title":"Cell Mol Life Sci: CMLS."},{"key":"B22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body.","volume":"8","author":"Warburg","year":"1927","journal-title":"J General Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutrit."},{"key":"B24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00000658-199203000-00014","article-title":"The effect of tumor bulk on the metabolic response to cancer.","volume":"215","author":"Koea","year":"1992","journal-title":"Ann Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s42255-024-01047-2","article-title":"Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet-mitochondria tethering to enhance \u03b2-oxidation and tumor cell proliferation.","volume":"6","author":"Meng","year":"2024","journal-title":"Nat Metab."},{"key":"B26","first-page":"176","article-title":"Glycerol dynamics in weight-losing cancer patients.","volume":"97","author":"Ed\u00e9n","year":"1985","journal-title":"Surgery."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1038650","DOI":"10.3389\/fimmu.2022.1038650","article-title":"Glucose metabolism and tumour microenvironment in pancreatic cancer key link in cancer progression.","volume":"13","author":"Dong","year":"2022","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"189208","DOI":"10.1016\/j.bbcan.2024.189208","article-title":"Mechanisms of cancer cachexia and targeted therapeutic strategies.","volume":"1879","author":"Li","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome.","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia.","volume":"333","author":"Das","year":"2011","journal-title":"Science."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-511x-5-4","article-title":"Influence of liver cancer on lipid and lipoprotein metabolism.","volume":"5","author":"Jiang","year":"2006","journal-title":"Lipids Health Dis."},{"key":"B32","first-page":"301","article-title":"Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.","volume":"92","author":"Motta","year":"2001","journal-title":"Minerva Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0009-8981(97)06533-9","article-title":"Lipoprotein (a) serum levels in patients with hepatocarcinoma.","volume":"262","author":"Basili","year":"1997","journal-title":"Clin Chimica Acta."},{"key":"B34","first-page":"3","article-title":"Cytokines as positive and negative regulators of tumor promotion and progression.","volume":"3","author":"Michiel","year":"1992","journal-title":"Sem Cancer Biol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1842975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:23:13Z","timestamp":1783916593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1842975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":34,"alternative-id":["10.3389\/fnut.2026.1842975"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1842975","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1842975"}}